ASH

May 16, 2016May 16, 2016

Epizyme to Present Clinical Data on NHL Treatment at ASH Lymphoma Conference

News

Epizyme, Inc., recently announced it will present four abstracts at the upcoming American Society of Hematology (ASH) Conference on Lymphoma Biology. The abstracts report data from its clinical development program of tazemetostat in patients ... Read more

February 16, 2016March 8, 2016

Negative-Data Clinical Trials in Lymphoma

To stay updated with the latest lymphoma clinical trials news, click here: http://bit.ly/1QoY2Uw Learn more about what happens after a lymphoma clinical trial ends here: http://bit.ly/1Rp5aB2

January 6, 2016March 8, 2016

Follicular Lymphoma News: Moving Beyond Chemotherapy

To learn more about follicular lymphoma, click here: http://bit.ly/1IQ8TFY

December 10, 2015December 10, 2015

Treatment-Naive Follicular Lymphoma Patients Respond Well to Ibrutinib Combo Therapy

News

AbbVie has announced results from its Phase 2 clinical trial showing that the combination of ibrutinib (Imbruvica) and rituximab was well-tolerated and achieved an overall response rate of 82% in treatment-naïve patients with ... Read more